BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 34285329)

  • 1. Bromodomain-containing protein BRPF1 is a therapeutic target for liver cancer.
    Cheng CL; Tsang FH; Wei L; Chen M; Chin DW; Shen J; Law CT; Lee D; Wong CC; Ng IO; Wong CM
    Commun Biol; 2021 Jul; 4(1):888. PubMed ID: 34285329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated virtual screening and MD simulation approaches toward discovering potential inhibitors for targeting BRPF1 bromodomain in hepatocellular carcinoma.
    Barman S; Bardhan I; Padhan J; Sudhamalla B
    J Mol Graph Model; 2024 Jan; 126():108642. PubMed ID: 37797430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uncovering the non-histone interactome of the BRPF1 bromodomain using site-specific azide-acetyllysine photochemistry.
    Barman S; Padhan J; Sudhamalla B
    J Biol Chem; 2024 Jan; 300(1):105551. PubMed ID: 38072045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular insights into the recognition of N-terminal histone modifications by the BRPF1 bromodomain.
    Poplawski A; Hu K; Lee W; Natesan S; Peng D; Carlson S; Shi X; Balaz S; Markley JL; Glass KC
    J Mol Biol; 2014 Apr; 426(8):1661-76. PubMed ID: 24333487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bromodomain-PHD finger protein 1 is critical for leukemogenesis associated with MOZ-TIF2 fusion.
    Shima H; Yamagata K; Aikawa Y; Shino M; Koseki H; Shimada H; Kitabayashi I
    Int J Hematol; 2014 Jan; 99(1):21-31. PubMed ID: 24258712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural insights into recognition of acetylated histone ligands by the BRPF1 bromodomain.
    Lubula MY; Eckenroth BE; Carlson S; Poplawski A; Chruszcz M; Glass KC
    FEBS Lett; 2014 Nov; 588(21):3844-54. PubMed ID: 25281266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deficiency of the chromatin regulator BRPF1 causes abnormal brain development.
    You L; Zou J; Zhao H; Bertos NR; Park M; Wang E; Yang XJ
    J Biol Chem; 2015 Mar; 290(11):7114-29. PubMed ID: 25568313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in the Chromatin Regulator Gene BRPF1 Cause Syndromic Intellectual Disability and Deficient Histone Acetylation.
    Yan K; Rousseau J; Littlejohn RO; Kiss C; Lehman A; Rosenfeld JA; Stumpel CTR; Stegmann APA; Robak L; Scaglia F; Nguyen TTM; Fu H; Ajeawung NF; Camurri MV; Li L; Gardham A; Panis B; Almannai M; Sacoto MJG; Baskin B; Ruivenkamp C; Xia F; Bi W; ; ; Cho MT; Potjer TP; Santen GWE; Parker MJ; Canham N; McKinnon M; Potocki L; MacKenzie JJ; Roeder ER; Campeau PM; Yang XJ
    Am J Hum Genet; 2017 Jan; 100(1):91-104. PubMed ID: 27939640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular architecture of quartet MOZ/MORF histone acetyltransferase complexes.
    Ullah M; Pelletier N; Xiao L; Zhao SP; Wang K; Degerny C; Tahmasebi S; Cayrou C; Doyon Y; Goh SL; Champagne N; Côté J; Yang XJ
    Mol Cell Biol; 2008 Nov; 28(22):6828-43. PubMed ID: 18794358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression atlas of the multivalent epigenetic regulator Brpf1 and its requirement for survival of mouse embryos.
    You L; Chen L; Penney J; Miao D; Yang XJ
    Epigenetics; 2014 Jun; 9(6):860-72. PubMed ID: 24646517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystallization and preliminary X-ray diffraction analysis of the BRPF1 bromodomain in complex with its H2AK5ac and H4K12ac histone-peptide ligands.
    Lubula MY; Poplawaski A; Glass KC
    Acta Crystallogr F Struct Biol Commun; 2014 Oct; 70(Pt 10):1389-93. PubMed ID: 25286946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Basis for the PZP Domain of BRPF1 Association with Chromatin.
    Klein BJ; Cox KL; Jang SM; Côté J; Poirier MG; Kutateladze TG
    Structure; 2020 Jan; 28(1):105-110.e3. PubMed ID: 31711755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deficient histone H3 propionylation by BRPF1-KAT6 complexes in neurodevelopmental disorders and cancer.
    Yan K; Rousseau J; Machol K; Cross LA; Agre KE; Gibson CF; Goverde A; Engleman KL; Verdin H; De Baere E; Potocki L; Zhou D; Cadieux-Dion M; Bellus GA; Wagner MD; Hale RJ; Esber N; Riley AF; Solomon BD; Cho MT; McWalter K; Eyal R; Hainlen MK; Mendelsohn BA; Porter HM; Lanpher BC; Lewis AM; Savatt J; Thiffault I; Callewaert B; Campeau PM; Yang XJ
    Sci Adv; 2020 Jan; 6(4):eaax0021. PubMed ID: 32010779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comprehensive study of epigenetic alterations in hepatocellular carcinoma identifies potential therapeutic targets.
    Bayo J; Fiore EJ; Dominguez LM; Real A; Malvicini M; Rizzo M; Atorrasagasti C; García MG; Argemi J; Martinez ED; Mazzolini GD
    J Hepatol; 2019 Jul; 71(1):78-90. PubMed ID: 30880225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological function and histone recognition of family IV bromodomain-containing proteins.
    Lloyd JT; Glass KC
    J Cell Physiol; 2018 Mar; 233(3):1877-1886. PubMed ID: 28500727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The multidomain protein Brpf1 binds histones and is required for Hox gene expression and segmental identity.
    Laue K; Daujat S; Crump JG; Plaster N; Roehl HH; ; Kimmel CB; Schneider R; Hammerschmidt M
    Development; 2008 Jun; 135(11):1935-46. PubMed ID: 18469222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isoform-specific involvement of Brpf1 in expansion of adult hematopoietic stem and progenitor cells.
    He Q; Hong M; He J; Chen W; Zhao M; Zhao W
    J Mol Cell Biol; 2020 Jun; 12(5):359-371. PubMed ID: 31565729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-based discovery of selective BRPF1 bromodomain inhibitors.
    Zhu J; Zhou C; Caflisch A
    Eur J Med Chem; 2018 Jul; 155():337-352. PubMed ID: 29902720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-Guided Design of IACS-9571, a Selective High-Affinity Dual TRIM24-BRPF1 Bromodomain Inhibitor.
    Palmer WS; Poncet-Montange G; Liu G; Petrocchi A; Reyna N; Subramanian G; Theroff J; Yau A; Kost-Alimova M; Bardenhagen JP; Leo E; Shepard HE; Tieu TN; Shi X; Zhan Y; Zhao S; Barton MC; Draetta G; Toniatti C; Jones P; Geck Do M; Andersen JN
    J Med Chem; 2016 Feb; 59(4):1440-54. PubMed ID: 26061247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computational studies with flavonoids and terpenoids as BRPF1 inhibitors: in silico biological activity prediction, molecular docking, molecular dynamics simulations, MM/PBSA calculations.
    Yalçin-Özkat G
    SAR QSAR Environ Res; 2022 Jul; 33(7):533-550. PubMed ID: 35822928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.